
|Articles|November 1, 2006
Breast cancer risk in subset of OC users
Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
2
FDA grants 510(k) clearance to Roche's cobas BV/CV assay
3
Natural Cycles receives FDA clearance for AI-powered fertility algorithm
4
HIV screening, PrEP counseling get stronger ACOG recommendation
5





